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Critical steps in clinical shotgun 
metagenomics for the concomitant 
detection and typing of microbial 
pathogens
Natacha Couto  1, Leonard Schuele1,2, Erwin C. Raangs1, Miguel P. Machado3, 
Catarina I. Mendes1,3, Tiago F. Jesus  3, Monika Chlebowicz1, Sigrid Rosema1, 
Mário Ramirez3, João A. Carriço3, Ingo B. Autenrieth2, Alex W. Friedrich1, Silke Peter2 & 
John W. Rossen  1
High throughput sequencing has been proposed as a one-stop solution for diagnostics and molecular 
typing directly from patient samples, allowing timely and appropriate implementation of measures for 
treatment, infection prevention and control. However, it is unclear how the variety of available methods 
impacts the end results. We applied shotgun metagenomics on diverse types of patient samples using 
three different methods to deplete human DNA prior to DNA extraction. Libraries were prepared and 
sequenced with Illumina chemistry. Data was analyzed using methods likely to be available in clinical 
microbiology laboratories using genomics. The results of microbial identification were compared 
to standard culture-based microbiological methods. On average, 75% of the reads corresponded to 
human DNA, being a major determinant in the analysis outcome. None of the kits was clearly superior 
suggesting that the initial ratio between host and microbial DNA or other sample characteristics were 
the major determinants of the proportion of microbial reads. Most pathogens identified by culture were 
also identified through metagenomics, but substantial differences were noted between the taxonomic 
classification tools. In two cases the high number of human reads resulted in insufficient sequencing 
depth of bacterial DNA for identification. In three samples, we could infer the probable multilocus 
sequence type of the most abundant species. The tools and databases used for taxonomic classification 
and antimicrobial resistance identification had a key impact on the results, recommending that efforts 
need to be aimed at standardization of the analysis methods if metagenomics is to be used routinely in 
clinical microbiology.
Classical microbial culture is still considered the gold standard in medical microbiology. Several molecular detec-
tion techniques have been implemented but these are generally geared towards specific pathogens (e.g. specific 
RT-PCR or microarrays). Even when unbiased molecular approaches are used, such as 16 S/18 S rRNA gene 
sequencing, these do not provide all the information that can be obtained by culturing, e.g., antimicrobial suscep-
tibility and molecular typing information. However, microbial culture is laborious and time-consuming and new 
methods are needed to replace it. Ideally, a single method should provide rapid identification and characterization 
of clinically relevant pathogens directly from a sample in order to guide therapy, predict potential treatment fail-
ures and to reveal possible transmission events.
Shotgun metagenomics (SMg) is a culture-independent technique that provides valuable information not 
only at the identification level, but also at the level of molecular characterization. Studies have shown that it has 
added value in terms of detection sensitivity and personalized treatment in clinical microbiology, when identify-
ing bacteria1,2 or viruses3. Indeed Gyarmati et al., 20164, used a sequence-based metagenomics approach directly 
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from blood to detect non-culturable, difficult-to-culture and non-bacterial pathogens. The authors were able, 
through SMg, to detect viral and fungal pathogens together with bacteria, which had not been detected through 
classical microbiology. Additionally, SMg can be used for infection prevention, having the potential to identify 
transmission events directly from clinical samples5. For example, SMg was proven valuable for the identification 
of inter-host nucleotide variations occurring after direct transmission of noroviruses causing gastroenteritis5. 
Hasman and colleagues (2014)1 were able to identify urinary pathogens directly from urine, as well as antimi-
crobial resistant genes compatible with the resistant phenotype determined through antimicrobial susceptibility 
testing. They also identified almost perfect phylogenetic matches between whole-genome sequence (WGS) data 
obtained by metagenomics and WGS of pure isolates.
Despite the promise of SMg of becoming a one-stop solution in clinical microbiology, SMg still has several 
challenges to overcome. One of the greatest challenges is the choice of the extraction and sequencing protocols, 
as well of the type of controls6. The extraction protocol should efficiently and specifically isolate microbial DNA/
RNA, while removing the host DNA/RNA7. However, the variety of clinical samples used in the diagnosis of 
distinct types of infection (e.g. tissues versus fluids), poses a serious challenge for standardization, an essential 
step if these methods are to be used by routine diagnostic laboratories. The sequencing protocol is also depend-
ent on the pathogens of interest (e.g. bacteria versus viruses), sequencing strategy (DNA and/or RNA), required 
turnaround time, sequencing depth and error tolerance6. The use of defined controls is necessary for validation of 
each experiment and these should be adapted for every type of infection and sample type and should consist of a 
combination of known positive specimens, pathogen-negative patient specimens and pathogen-negative patient 
specimens spiked with live microorganisms or pure DNA6.
Another potential challenge are the metagenomics analysis tools. Recent studies have evaluated the dif-
ferent SMg sequence classification methods8. These use different methodologies for classification: sequence 
similarity-based methods, sequence composition-based methods and hybrid methods8. They differ not only in 
the algorithms for detecting the microorganisms present, but also in the databases used. This high variability 
leads to different results, not only at the microorganism classification level but also when evaluating the relative 
abundance of these pathogens8. A recent study evaluated the accuracy of 38 bioinformatics methods using both 
in silico and in vitro generated mock bacterial communities. Dozens to hundreds of species were falsely predicted 
by the most popular software, and no software clearly outperformed the others8. In the absence of studies com-
paring the outputs of different analysis methods in clinical samples, users may decide which methods to use based 
on personal experience with a given tool, availability of the tool in the laboratory or its ease of use. This poses a 
great challenge when providing reproducible results and creates uncertainty regarding the reliability of the infor-
mation derived. This is a major barrier to the implementation of SMg approaches in routine clinical microbiology 
laboratories.
In this study, the aim was to identify the critical steps when using SMg for the identification and character-
ization of microbial pathogens directly from clinical specimens using methods that are likely to be available 
in clinical microbiology laboratories wanting to implement genomics for pathogen identification or molecular 
epidemiology studies. For this purpose, we used three human-DNA depletion kits and evaluated a diverse set 
of bioinformatics tools (commercial and non-commercial) in order to investigate how well they performed and 
what the differences would be in terms of taxonomic classification, antimicrobial resistance gene detection and 
typing directly from patient samples, bypassing culture.
Results
Classical identification. Nine body fluid samples and one tissue sample from 9 different patients were 
sequenced, including one sample from peritoneal fluid, five from pus (3 abscesses and 2 empyemas), two 
from synovial fluid of knees with prosthesis, one from sputum and one from a bone biopsy (Table 1). In total 
15 different isolates obtained from the 10 samples were considered of possible clinical significance and were 
selected for species identification and antimicrobial susceptibility testing during routine work up of the samples 
(Tables 2, 3 and 4). In samples 2 and 3, only one colony-forming unit (CFU) of Escherichia coli and Staphylococcus 
Sample 1 Sample 2 Sample 3 Sample 4 Sample 5 Sample 6 Sample 7 Sample 8 Sample 9 Sample 10
Negative 
control







































































































Table 1. Characteristics of the samples and mapping of trimmed reads against a human genome hg19 (%) using 
CLC Genomics Workbench v10.0.1.
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epidermidis, respectively, was detected after 48 hours of incubation. In samples 2 and 5, the anaerobic cultures 
were mixed to such an extent, that no further characterization of the colonies was performed, and the results were 
reported as anaerobic mixed culture.
Antimicrobial susceptibility testing, revealed three isolates to be fully susceptible, while the others were 
resistant to at least one antimicrobial. Two isolates, one Staphylococcus haemolyticus and one S. epidermidis were 
oxacillin-resistant and positive in the cefoxitin test (Vitek 2).
There was fungal growth in 2 samples (1 and 5) that included two Candida species (one Candida glabrata and 
one Candida albicans). The different bacterial and fungal species identified in each sample are shown in Tables 2, 
3 and 4.
Comparison of standard procedures and shotgun metagenomics for the identification of clini-
cally relevant pathogens. The tools used for taxonomic classification are shown in Fig. 1. The total num-
ber of reads and the total number of reads mapped against the human genome (hg19) varied between samples, 
ranging from 3.5% to 98.9% (Table 1). The abundance of human reads was not determined by the type of sample 
but was probably influenced by individual characteristics of each sample and the success of the methods used 
in depleting the human DNA. We identified the microorganisms present using different taxonomical methods, 
including three Unix-based tools (Kraken, Metaphlan2 and MIDAS), web-based tools including both commercial 
and freely available solutions (BaseSpace, Taxonomer and CosmosID) and one commercial approach having a 
graphical interface (CLC Genomics Workbench v10.0.1). The taxonomic classification results for each sample 
are presented in Tables 2, 3 and 4. In 8 samples, all the microorganisms identified by classical culture were also 
identified through metagenomics (using at least one method). In sample 2, two of the bacterial species identified 
by classical culture, i.e., E. coli and one Enterococcus avium were not identified through shotgun metagenomics 
and in sample 3 there was no concordance between the results of MALDI-TOF and the taxonomical classifica-
tion methods at the species level (Tables 2, 3 and 4). We identified Ochrobactrum intermedium in the negative 
control, but in low amounts (1.0% of the reads mapped to the reference genome with the accession number 
NZ_ACQA01000002 and only 1.4% of the reference genome was covered). The sensitivity and positive predictive 
value of each classification method is shown in Table 5.
Determination of antimicrobial resistance. Metagenomics provides other sequence information 
in addition to pathogen detection. We determined the presence of antimicrobial-resistance genes in the SMg 
sequence data and compared the results with those obtained from WGS and phenotypic resistance testing 
(Table 6).
Antimicrobial resistance genes found with CLC Genomics Workbench and ReMatCh in samples 1, 7 and 9 
correlated well with phenotypic results. However, in the other 7 samples, not all antimicrobial resistance genes that 
could explain the phenotypic profile were identified. In addition, in samples 2, 5, 7 and 10, ReMatCh detected differ-
ent resistance genes compared to those reported by CLC Genomics Workbench (Table 6). Some of these differences 
(genes norA, blaSST-1, fusA) were due to slight differences in the databases used, however, the other resistance genes 

















































3 1 S. epidermidis —# S. aureus (0.2%) Not identified* Not identified*





































6 103 E. faecium E. faecium E. faecium (0.77%) Not identified* Not identified*
7 102 S. aureus —# S. aureus (82.9%) S. aureus (100%) S. aureus (100%)
8 103 O. intermedium O. intermedium O. anthropi (21.3%) O. intermedium (99.4%) O. intermedium (99.1%)
9 103 S. aureus S. aureus S. aureus (22.9%) S. aureus (100%) S. aureus (100%)
10 103 S. marcescens —# S. marcescens (64.7%) S. marcescens (99.1%) S. marcescens (100%)
Table 2. Microorganisms identified by conventional methods, WGS and using shotgun metagenomics and the 
taxonomic classification methods in Unix. aThe number of colonies of a given species was estimated from the 
number of colonies with the same morphology on the same plate; bThe relative abundance is calculated using 
total number of reads as denominator; cThe relative abundance is calculated with the total number of classified 
reads as denominator; dminiKraken database was used; #Although there was a laboratory identification, no 
isolates were available for WGS; *No reads matched that specific pathogen, not even at the genus level.
www.nature.com/scientificreports/
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antimicrobial resistance genes usually found in anaerobic bacteria. These were not reported by classical microbiol-
ogy methods, probably because they were not considered relevant pathogens worthy of subsequent susceptibility 
study (mixed anaerobic culture).
The SEAR app in BaseSpace (the only one available for antimicrobial resistance gene detection) crashed sev-
eral times, although we performed the analysis repeatedly, using different parameters. We were only able to get 
results in 3 samples, with no resistance genes detected.
MLST and wgMLST analysis. In three cases when SMg data covered ≥ 93% of the genome we were able to iden-
tify the ST, which corresponded to the one found using WGS of the isolated bacteria using CLC Genomics Workbench 
(n = 2) and metaMLST (n = 1). These results are summarized in Table 7. Assembled genomes and metagenomes, were 
compared by wgMLST analysis using Ridom SeqSphere+. Figure 2 shows examples of the allele difference between 
the genomes obtained through WGS versus the genomes obtained through shotgun metagenomics.
Characterization of mobile genetic elements. Two different approaches, i.e. CLC Genomics 
Workbench and Bowtie2 were used to identify plasmids present in the sequence data. Both approaches used 
mapping of sequences against the same plasmid database. Since some plasmids present in the database are very 
similar and sequence reads may be mapped to more than one plasmid, we used the pATLAS tool, which provides 
an overview of the nodes (representing plasmid sequences) and links between plasmids (which connect similar 
plasmids), to enable the visualization of the plasmids identified (Fig. 3). A color gradient indicates the sequence 
coverage of the plasmids. In most cases, the same plasmids were identified by both approaches, with some small 
differences in sequence coverage. When comparing the plasmids identified in the SMg dataset versus the WGS 
data, most of the plasmids were also detected in the isolates (an example is shown in Fig. 4). However, some 
plasmids were not identified in any of the isolated bacteria and were probably residing in low-abundant species.
Discussion
This study evaluated the suitability of SMg for the microbiological diagnosis and (patho- and epi-) typing of 
microorganisms directly from real patient samples. The whole procedure took between 48–54 hours to complete, 
which is shorter than culture-based methods if one includes typing. However, the amount of information derived 
from SMg in most cases, did not overcome the necessity for pathogen isolation and subsequent (phenotypic and 
genotypic) typing, which can take up to 1–2 weeks (particularly in slow-growing organisms). Nevertheless, SMg 
can help guide antimicrobial therapy and can be helpful in cases where there is a suspicion of transmission and 
there is a need to quickly determine the genetic relationship between pathogens, although the success of SMg in 
individual patient samples can be highly variable, as reported here.
Different bioinformatics pipelines were evaluated to identify potential differences between them and identify 
those which could provide the clinical microbiologist with the maximum of relevant and accurate information. 
In terms of microbial identification, in both Unix and web-based approaches we would recommend MetaPhlAn, 













































3 1 S. epidermidis —# Not identified* S. aureus (4%)































6 103 E. faecium E. faecium Not identified* E. faecium (4.0%)
7 102 S. aureus —# S. aureus (100%) S. aureus (95.5%)
8 103 O. intermedium O. intermedium O. intermedium (86.0%) O. intermedium (91.2%)
9 103 S. aureus S. aureus S. aureus (100%) S. aureus (81.2%)
10 103 S. marcescens —# S. marscescens (100%) S. marcescens (79.7%)
Table 3. Microorganisms identified by conventional methods, WGS and using shotgun metagenomics and the 
taxonomic classification methods in CLC Genomics Workbench. aThe number of colonies of a given species was 
estimated from the number of colonies with the same morphology on the same plate; bThe relative abundance 
is calculated with the total number of classified reads as denominator; cBased on the Output Quality Report; 
#Although there was a laboratory identification, no isolates were available for WGS; *No reads matched that 
specific pathogen, not even at the genus level.
www.nature.com/scientificreports/
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should be used in the context of the CLC Genomics Workbench, since it had a higher sensitivity and PPV com-
pared to the Taxonomic Profiling tool.
In a clinical setting, a combination of high sensitivity and high PPV of any new method is key. Popular software 
designed for bacterial identification can predict dozens to hundreds of species in in vitro generated bacterial com-














































































3 1 S. epidermidis —# S. aureus (100%) S. aureus (0.1%) Not identified* S. pseudintermedius (3.4%) Not identified*


























































6 103 E. faecium E. faecium E. faecium (4.2%) E. faecium (14.8%) E. faecium (5.5%) E. faecium (1.4%) E. faecium (4.1%)
7 102 S. aureus —# S. aureus (100%) S. aureus (93.8%) S. aureus (100%) S. aureus (14.2%) S. aureus (100%)







9 103 S. aureus S. aureus S. aureus (100%) S. aureus (99.5%) S. aureus (100%) S. aureus (12.7%) S. aureus (100%)
10 103 S. marcescens —# S. marcescens (32.5%)
S. marcescens 
(94.8%) Serratia spp. (100%) S. marcescens (1.4%)
S. marscescens 
(38.4%)
Table 4. Microorganisms identified by conventional methods, WGS and using shotgun metagenomics and 
the taxonomic classification methods in webpages (BaseSpace, Taxonomer and CosmosID). aThe number of 
colonies of a given species was estimated from the number of colonies with the same morphology on the same 
plate; bThe relative abundance is calculated using total number of reads as denominator; cThe relative abundance 
is calculated with the total number of classified reads as denominator; dminiKraken database was used; eFull 
Analysis mode was used; #Although there was a laboratory identification, no isolates were available for WGS; 
*No reads matched that specific pathogen, not even at the genus level.
Figure 1. Scheme of the bioinformatic analysis of the metagenomics samples.
www.nature.com/scientificreports/
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culture-based methods. For both Kraken and Taxonomer, relative abundance cut-off values may be required to 
limit the number of species identified. However, which cut-off values should be used are a matter of debate, since 
in some cases, even if applying a cut-off value as low as 1.0% (comparable to what was found in the negative con-
trol) would have resulted in decreased sensitivity (e.g. the Streptococcus anginosus identified by culture in Sample 
5 would have been disregarded). The methods that employ several parameters to infer microbial identification are 
superior, because they not only rely on the relative abundance of bacterial species, but also on the genome cover-
age and on the proportion of the genome that was covered. On the other hand, in some cases SMg may be more 
sensitive than culture in identifying pathogens, reflecting the higher sensitivity or the capacity to detect bacterial 
species which are non-culturable in the conditions used or that are no longer culturable, such as due to prior anti-
microbial therapy. In such cases, other methods like 16 S rRNA gene sequencing or the recently described 16S-23S 
rRNA-coding region sequencing method9 may be used for discrepancy analyses. However, here we decided to use 
culture-based methods as the gold standard, since this is still the method of choice in clinical microbiology.
One limitation of this study was the exclusion of culture-negative samples and thus their inclusion would 
have affected the calculation of the specificity values. However, as mentioned above, culture-negative samples do 
not necessarily mean that the samples are pathogen-free, but it might only reflect the low sensitivity or capacity 
of culture-based methods to detect non-culturable bacterial species. As with other (molecular) methods, several 
controls should be included to validate the obtained results, including a negative control. In our negative control, 
we detected an O. intermedium strain, although with only 1.0% of the reads mapping to the reference genome 
and covering only 1.4% of the reference genome (accession number NZ_ACQA01000002). These results may be 
due to contamination during library preparation (e.g. sample-to-sample contamination prior to indexing), the 
result of sequencing artefacts (e.g. demultiplexing errors), or to incorrect classification during data analysis (e.g. 
highly similar regions)3. Our samples and sequencing libraries were handled in laminar flow cabinets; however, 
we cannot also exclude the possibility of contamination. Furthermore, the reagents used may also be or become 
contaminated with DNA leading the detection of these contaminating species, something that has been described 
previously7. This poses a challenge for interpretation, because some positive samples also had very low numbers 
of reads for some pathogens (<1%). When approaching this limit of detection, small numbers of pathogen reads 
will be difficult to interpret, as they can represent true-positives with low abundance in the sample, or artifacts 
such as contamination during library preparation3.
In terms of antimicrobial resistance gene detection, ReMatCh (Unix) and the CLC Genomics Workbench 
Find Resistance tool gave comparable results. Since ReMatCh (Unix) performs the analysis at the read level, while 
CLC Genomics Workbench performs it at the contig level, we suggest that both strategies should be employed in 
parallel when looking for antimicrobial resistance genes. It is also important to emphasize that the contig-level 
approach employed by CLC Genomics Workbench may give negative results if the sequence coverage is set to a 
high percentage (e.g. above 80%). This is due to the assembly method, which may split the antimicrobial resist-
ance genes into different contigs, when the number of reads is too low. This phenomenon was observed in Sample 
1, for the aac(6’)-aph(2”) gene, which was split into three different contigs, each part corresponding to less than 
40% of the gene. Only when applying a cut-off value of ≥20% for sequence coverage could we identify all three 
parts of the gene, which in total corresponded to 89% of the entire sequence. Finally, it is important to point out 
that the ResFinder database (used here), and other databases, focus on acquired genes, not including chromo-
somal point mutations resulting in antimicrobial resistance. However, a recently developed tool, PointFinder, was 
added to ResFinder for the detection of chromosomal point mutations associated with antimicrobial resistance10 
and an updated database will be available soon.
Another challenge is to infer where these antimicrobial resistance genes are located (chromosome or plasmid). 
The study of mobile genetic elements, including plasmids, carrying antimicrobial resistance genes present in clin-
ical samples is important to predict possible treatment failures and the spread of resistance within and across bac-
terial species. When performing bacterial isolation followed by WGS, information on polymicrobial infections 
Method












Culture/MALDI-TOF 9 9 0 0 100% 100%
MetaPhlAn (BaseSpace) 16 7 9 2 78% 44%
Genius (BaseSpace) 35 8 27 1 89% 23%
Kraken (BaseSpace) 959 7 952 2 78% 1%
Taxonomer (Full Analysis) 4649 8 4641 1 89% 0%
CosmosID 35 8 27 1 89% 23%
Taxonomic Profiling (CLC 
Genomics Workbench v10.0.1) 17 6 11 3 67% 35%
Best match K-mer spectra (CLC 
Genomics Workbench v10.0.1) 12 8 4 1 89% 67%
Kraken (Unix) 198 7 191 2 78% 4%
MetaPhlAn2 (Unix) 15 7 6 4 75% 75%
MIDAS (Unix) 34 7 26 2 88% 50%
Table 5. Performance of the different taxonomic classification methods for each sample. Sensitivity and positive 
predictive value were calculated using culture/MALDI-TOF as standards. aExcluding the samples with non-
identified anaerobic bacteria (Samples 2 and 5). Abbreviations: PPV, positive predictive value.
www.nature.com/scientificreports/
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may be lost. This is mainly driven by a bottleneck in culture, where some bacterial species are not isolated with 
standard work up protocols (frequently anaerobes and slow-growing organisms). The presence of antimicrobial 
resistance genes in plasmids of bacteria other than those isolated through culture poses a risk since they are 
not identified by conventional methods but could potentially be horizontally transmitted to pathogenic bacteria 
under the antimicrobial selective pressure of treatment. Antimicrobial administration may also select minority 
populations where these resistance determinants are found. Furthermore, the understanding of how plasmids are 
shared by different bacteria in a bacterial community (e.g. within an infection site or in the gut) can improve our 
understanding of how these elements disseminate across species and from patient to patient11. The SMg approach 
is clearly more efficient than culture in identifying the “cloud” of plasmids present in a given sample (Fig. 4) and 
which can be potentially transferred to more pathogenic species generating problems of resistance, as was the case 
with the emerge of vancomycin resistance S. aureus12.
Whole-genome sequencing has been used extensively for several purposes13 and is considered to have the 
potential of playing an important role in clinical microbiology14. It is the ongoing goal of medical molecular 
microbiology to develop faster typing methods that can be used for outbreak surveillance. For this purpose, we 
assembled the metagenomics data and compared it with the assemblies given by WGS. Surprisingly, the assem-
blies provided by SPAdes in BaseSpace were closer to the assemblies provided by WGS. When comparing the 
genomes obtained through WGS and SMg, we could see that in 4 out of 8 bacterial isolates the number of different 
alleles was ≤7. This showed the potential of SMg to draw phylogenetic relationships from uncultured bacterial 
genomes, although more potentially limited than those obtained using WGS data from axenic cultures. As for 
the detection of resistance genes, a key limiting factor may be the number of bacterial reads, reflected in a lower 
genome coverage (e.g. samples 4 and 6). In these cases, we would have to either improve the human-DNA deple-
tion step, improve the microbial enrichment or perform sequencing at a higher sequencing depth to have enough 
microbial reads to be able to get a more appropriate genome coverage. Yet, this last step will severely raise the 
sequencing costs, which might render the methodology unfeasible for routine application.
In this study, we evaluated the results of metagenomics pipelines using three different methods. CLC 
Genomics Workbench has advantages over the other methods. It does not require previous knowledge of 
Unix-based tools, it is arguably the most user-friendly and delivered reliable results for microbial identification 
and antimicrobial resistance gene detection. The downside was the assembly approaches, which provided lower 
wgMLST allele detection, when compared to the assemblies using SPAdes (BaseSpace and Unix). BaseSpace, the 
other commercial solution, on the other hand, provided only a few tools that can be used for metagenomics data. 
Furthermore, since Illumina did not develop the apps themselves, they offered no direct support. Contacting the 
developers (via email and posting on their forum) does not guarantee a solution to the issues in a time frame com-
patible with a routine clinical microbiology laboratory work. The dependence and no direct control over a third 





Conventional susceptibility testing 
(VITEK 2)b
WGS CLC Genomics 
Workbench
Shotgun metagenomics
ReMatCh (Unix) CLC Genomics Workbencha
1 E. faeciumS. haemolyticus
LEV, ERY, CLI
OXA, GEN, CIP, FOS, ERY, CLI
erm(B), msr(C), ant(6’)-Ia, 
aph(3’)-III, dfrG
blaZ, mecA, ant(6’)-Ia, aph(3’)-
III, aac(6’)-aph(2”), erm(C), 
mph(C), msr(A), dfrG
erm(B), msr(C), ant(6’)-Ia, 
aph(3’)-III, aac(6’)-aph(2”), 
blaZ, mecA, erm(C), mph(C), 
msr(A), dfrG
erm(B), msr(C), ant(6’)-Ia, 
aph(3’)-III, aac(6’)-aph(2”), 


















catS, lnu(D), lsa(C), cepA-44, 
tet(Q), fusA
3 S. epidermidis OXA, GEN, TEC, FUS, CIP, ERY, CLI —
# Not detected Not detected



























6 E. faecium PEN, AMX, CFX, IMP, GENhl, STRhl, LEV, ERY, CLI, AMP/SUL
erm(B), msr(C), ant(6’)-Ia, 
aph(3’)-III, aac(6’)-aph(2”), dfrG Not detected Not detected
7 S. aureus PEN blaZ blaZ, norA blaZ
8 O. intermedium AMX, PIP/TAZ, CFX, CFT, CTZ, IMP, FOX, TOB, FOS, NIT, TMP blaOCH-2 blaOCH-5 blaOCH-2
9 S. aureus PEN —# blaZ blaZ
10 S. marcescens AMX, AMC, CFX, FOX, NIT, POL —# blaSST-1, tet(41), oqxB, aac(6’)-Ic tet(41), oqxB, aac(6’)-Ic
Table 6. Antimicrobial resistance phenotypes and antimicrobial resistance genes detected using different 
approaches. aThe analysis aborted when the script tried to connect to NCBI. bOnly non-susceptibility is 
indicated. Abbreviations: AMP/SUL, ampicillin/sulbactam; AMX, amoxicillin; AMC, amoxicillin/clavulanate; 
CFX, cefuroxime; FOS, fosfomycin; FOX, cefoxitin; CIP, ciprofloxacin; CLI, clindamycin; DOX, doxycycline; 
ERY, erythromycin; FUS, fusidic acid; GEN, gentamicin; GENhl, gentamicin high-level; LEV, levofloxacin; NIT, 
nitrofurantoin; PEN, penicillin; POL, polymyxin B; STRhl, streptomycin high-level; TEC, teicoplanin.
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Workbench v10.1.1 CLC Genomics Workbench v10.1.1 metaMLST (Unix-based)
1 E. faeciumS. haemolyticus
ST117
ST25
Not detected (6 alleles identified correctly)
















3 S. epidermidis —# Not detected Not detected






















6 E. faecium ST117 Not detected Not detected
7 S. aureus ST30 ST30 ST667
8 O. intermedium — — —
9 S. aureus —# Not detected Not detected
10 S. marcescens —# — —
Table 7. Results of MLST using by whole genome sequencing and shotgun metagenomics. Abbreviations: ST, 
sequence type.
Figure 2. Minimum-spanning tree based on wgMLST allelic profiles of two S. aureus genomes and two E. coli 
genomes obtained through SM and WGS in comparison to reference strains 04-02981 (GenBank accession 
number NC_017340) and 06-00048 (NZ_CP015229), respectively. Each circle represents an allelic profile based 
on sequence analysis. The numbers on the connecting lines illustrate the numbers of target genes with differing 
alleles.
Figure 3. (a) Overview of the nodes (representing plasmid sequences) and links between plasmids (connecting 
similar plasmids) found in Sample 1 (SMg) using the pATLAS tool. (b) A closer look at one of the cloud of 
plasmids. The color gradient in each cloud of plasmids represents the plasmid sequence coverage (SC), varying 
between 0–0.79 (grey) and 0.80–1 (red gradient).
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BaseSpace. Finally, the Unix-based pipeline complemented the data on antimicrobial resistance genes but did not 
offer better results in terms of microbial identification and MLST typing. However, many more freely available 
tools for this last purpose could have been used, potentially improving on the results obtained. Reference-guided 
assembly approaches, taking advantage of the species information derived in the first steps of our analysis pipe-
lines, will deserve further study in the future since these may provide higher quality assemblies from metagen-
omics data. The main advantage of an open-source approach is its flexibility since it allows the user to choose the 
most adequate method for each desired outcome.
There were several limitations to this study. First, the number of samples included was low and some of the 
bacterial isolates were not available for further WGS analysis. However, the extended data analyses performed 
in each sample limited the number of samples to be included. It is our intention to move forward with the most 
adequate pipelines for each purpose and apply them to additional patients’ samples. Second, the samples differed 
greatly from each other. However, in our point of view, this was beneficial to the study, since it did not bias the 
analyses as it could have happened if only one type of sample had been used. Finally, we used three different 
extraction methods that could have influenced the final results. Yet, as can be seen in Table 1, the number of 
human reads differed between samples, even when using the same extraction kit. This suggests none of the kits 
is clearly superior to the others and that the ratio between host and microbial DNA or other individual sample 
characteristics will be the major determinants of the proportion of microbial reads.
In conclusion, this study showed the potential but also highlighted the problems of implementing shotgun 
metagenomics for the identification and typing of pathogens directly from clinical samples. Based on the results 
obtained here we can conclude that the tools and databases used for taxonomic classification and antimicrobial 
resistance will have a key impact on the results, cautioning about the comparison between studies using different 
methods and suggesting that efforts need to be directed towards standardization of the analysis methods if SMg 
is to be used routinely in clinical microbiology.
Methods
Sample collection. Nine body fluid samples and one tissue sample entering the Medical Microbiology lab-
oratory were selected for metagenomics sequencing. These included one sample from peritoneal fluid, five from 
pus (3 abscesses and 2 empyema), two from synovial fluid of knees with prosthesis, one from sputum and one 
from a bone biopsy (Table 1). All samples were stored at 4 °C for a variable period (2–10 days). The samples used 
for the present analyses were collected during routine diagnostics and infection prevention and control investi-
gations. All procedures were carried out according to guidelines and regulations of UMCG concerning the use 
of patient materials for the validation of clinical methods, which are in compliance with the guidelines of the 
Federation of Dutch Medical Scientific Societies (FDMSS). Every patient entering the UMCG is informed that 
samples taken may be used for research and publication purposes, unless they indicate that they do not agree to 
it. This procedure has been approved by the Medical Ethical Committee of the UMCG. Informed consent was 
obtained from all individuals or their guardians prior to study participation. All samples were used after perform-
ing and completing a conventional microbiological diagnosis and were coded to protect patients’ confidentiality. 
All experiments were performed in accordance with the guidelines of the Declaration of Helsinki and the insti-
tutional regulations.
Figure 4. A heatmap comparing the identified plasmids using bowtie2 in S. haemolyticus WGS (1), E. faecium 
WGS (2) and in the SMg dataset (3) isolated from sample 1.
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Classic culturing and susceptibility testing. The samples were cultured following methods routinely 
used in our institution. Briefly, samples were streaked onto five plates (Mediaproducts BV, Groningen, The 
Netherlands) - blood agar (aerobic), chocolate agar (aerobic), McConkey agar (aerobic), Brucella agar (anaero-
bic) and Sabouraud Dextrose + AV (aerobic) - and incubated overnight under aerobic and anaerobic atmosphere 
at 37 °C. The two pus samples were also plated onto Phenylethyl alcohol sheep blood agar (PEA), Kanamycin 
vancomycin laked blood (KVLB) agar and Bacteroides bile esculin (BBE) agar and incubated under anaerobic 
conditions overnight. The isolates recovered were subjected to susceptibility testing by Vitek 2 using either the 
AST-P559 (Gram-positive bacteria) or the AST-N344 (Gram-negative bacteria) card (bioMérieux, Marcy-l'Étoile, 
France) and identified by MALDI-TOF MS (Bruker Daltonik, Gmbh, Germany) using standard protocols.
DNA extraction, library preparation and sequencing. The DNA for metagenomic sequencing was 
isolated using the Ultra-Deep Microbiome Prep (Molzym Life Science, Bremen, Germany), Micro-Dx™ kit 
(Molzym Life Science) or QIAamp DNA Microbiome Kit (Qiagen, Hilden, Germany) directly from the clinical 
samples and a negative control consisting of a mock sample of DNA and RNA free water (Table 1). These kits 
include human DNA depletion steps. The QIAamp DNA Microbiome Kit was used according to the manufac-
turer’s protocol with an additional 5 min air-dry step before elution. For microbial lysis, a Precellys 24 homoge-
nizer (Bertin, Montigny-le-Bretonneux, France) set to 3 times 30 seconds at 5000 rpm separated by 30 seconds 
was used. After extraction, DNA was quantified with the Qubit 2.0 (Life Technologies, ThermoFisher Scientific, 
Waltham, Massachusetts, EUA) and NanoDrop 2000 (ThermoFisher Scientific). The DNA quality was assessed 
using the Genomic DNA ScreenTape and Agilent 2200 TapeStation System (Agilent Technologies, California, 
United States of America). Isolated DNA was purified using Agencourt AMPure XP beads (Beckman Coulter, 
California, United States of America) according to the manufacturer’s instructions, to eliminate small DNA frag-
ments and chemical contaminants (e.g. benzonase). The DNA was then diluted to 0.2 ng/µl and 1 ng was used 
for the library preparation, using the Nextera XT Library Preparation kit (Illumina, California, United States of 
America), according to the manufacturer’s protocol. Cluster generation and sequencing were performed with 
the MiSeq Reagent Kit v2 500-cycles Paired-End in a MiSeq instrument (Illumina). Samples were sequenced in 
batches of 5 samples on a single flow cell.
For the DNA extraction of bacterial isolates (when an isolate was recovered from culture), we used the 
UltraClean Microbial DNA Isolation Kit (Mo Bio), with some modifications. We started with solid cultures and 
resuspended a 10 µl-loopfull of culture directly into the tube with the microbeads and microbead solution. The 
library preparation, cluster generation and sequencing was performed as described above. Strains were sequenced 
in batches of 12 to 16 on a single flow cell.
Bioinformatics analyses. In order to evaluate and compare the accuracy and reliability of the bioinformat-
ics analyses in providing the closest results to culture and WGS of any cultured isolates, three different pipelines 
(two commercially and one freely available) were used (Fig. 1). Different tools to perform raw read quality con-
trol, filtering and trimming were used and reads were mapped against the human genome (hg19) before perform-
ing taxonomic classification. Reads mapping to hg19 where removed from the analysis to increase the efficiency 
of the bioinformatics tools. Typing (MLST), phylogenetic analysis, plasmid analysis, detection of antimicrobial 
resistance and virulence genes was performed. To determine the appropriateness of SMg as predictor of the WGS 
(chromosome and plasmids), SMg results obtained were compared with the results of WGS of any bacterial iso-
lates obtained from culturing the sample.
All the parameters used in each approach are available in Supplementary Table 1.
Unix-based approach. For the metagenomics data, read quality control and cleaning was performed using 
FastQC v0.11.5 and Trimmomatic v0.36, respectively, through the INNUca v2.6 pipeline (https://github.
com/B-UMMI/INNUca), excluding assembly and polishing. Using a reference mapping approach against the 
human genome (UCSC hg19), human reads were discarded using Bowtie 2 v2.3.215 and SAMtools v1.3.116. Those 
paired reads that did not map against the human genome were used in subsequent analyses. The bacterial species 
were identified through Kraken v0.10.5-beta17 using the miniKraken database (pre-built 4 GB database con-
structed from complete bacterial, archaeal and viral genomes in RefSeq, as of Dec. 8, 2014), MIDAS18 using the 
midas_db_v1.2 database (>30,000 bacterial reference genomes, as of May 9, 2018) and MetaPhlAn2 v2.019 using 
the database provided by the tool (~13,500 bacterial and archaeal, ~3,500 viral, and ~110 eukaryotic reference 
genomes, as of May 9, 2018). The sequence type (ST) was obtained through metaMLST v1.120 based on the met-
amlstDB_2017. Antimicrobial resistance genes were detected using ReMatCh v3.2 (https://github.com/B-UMMI/
ReMatCh), a read mapping tool that uses Bowtie 2 v2.3.215 and the following rules for gene presence/absence: 
genes were considered present when ≥80% of the reference sequence was covered and the sample sequence was 
≥70% identical to the one used as reference. For that, ResFinder database (2231 genes, downloaded on 29-06-
2017) was used as reference and, due to the low coverage of microbial metagenomics samples, a minimal coverage 
depth of 1 read was set to consider a reference sequence position as covered (and therefore present in the sample 
data), as well as to perform base call (used for sequence identity determination). Finally, the assembly was accom-
plished through SPAdes v3.10.121.
Plasmid detection was achieved by running the script PlasmidCoverage (https://github.com/tiagofilipe12/
PlasmidCoverage), using the plasmid sequences downloaded from NCBI RefSeq (ftp://ftp.ncbi.nlm.nih.gov/
genomes/refseq/plasmid/, as of May 11, 2017). The script uses Bowtie 2 v2.2.915, to map the pre-processed input 
reads against the plasmid database (bowtie2 index for all plasmid sequences). For bowtie2 we used the ‘-k’ option, 
allowing each read to map to as many plasmid sequences as present in the NCBI RefSeq plasmid database (since 
plasmid sequences are modular)22,23. Then, this pipeline used SAMtools v1.3.116 to estimate the coverage for each 
position, and reported the length of plasmid sequence covered (in percentage) and average depth (mean number 
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of reads mapped against a given position in each plasmid). Plasmids with less than 80% of its length covered were 
excluded from the final results in line with what has described elsewhere11. The pATLAS tool (http://www.patlas.
site) was used to visualize which plasmids were present.
For the WGS reads of the bacterial isolates, the whole INNUca v2.6 pipeline was run, including SPAdes assem-
bly and polishing. Plasmids were detected as mentioned previously.
Commercial-based approach. The fastq files containing the reads were uploaded into CLC Genomics Workbench 
v10.1.1, using the following options: Illumina import, paired-reads, paired-end (forward-reverse) and minimum 
distance of 1 and a maximum distance of 1000 (default). The trimming was performed using the default settings, 
except the quality trimming score limit was set to 0.01 and we added a Trim adapter list containing Illumina 
adapters. The mapping was performed with the Map Reads to Reference tool, using the hg19 genome as reference. 
The default settings were used with the addition of the collect un-mapped reads option. The de novo assembly tool 
was used for the assembly (even for the metagenomics reads) and, apart from the word size, which was changed 
to 29, all the settings were default. Two tools were used for the microbial identification, Taxonomic Profiling 
and Find Best Matches using K-mer Spectra (Microbial Genomics Module). In both, the bacterial and fungal 
databases were downloaded from NCBI RefSeq (with the Only Complete Genomes option turned off; minimum 
length 500,000 nucleotides) on 08-07-2017 (bacterial, 70,868 sequences) and 25-05-2017 (fungal, 377 sequences). 
The antimicrobial resistance genes were detected, based on the assembled contigs, using the Find Resistance 
tool (Microbial Genomics Module) and were initially only considered present when they were ≥70% identical 
to the reference and ≥80% of the sequence was covered. The analysis was also repeated using ≥40% and ≥20% 
of sequence coverage for comparison purposes. The database containing the antimicrobial resistance genes was 
downloaded directly to the software from ResFinder (https://cge.cbs.dtu.dk/services/data.php, downloaded on 
05-07-2017, 2156 sequences). The MLST was determined through the Identify MLST tool (Microbial Genomics 
Module), using all MLST schemes available at PubMLST (04-03-2017). The same database used for plasmid 
detection in Unix, was used for mapping the reads in CLC Genomics Workbench. Again, plasmids with less than 
80% of its length covered were excluded from the final results. For WGS reads we used the Trim Sequences tool 
and the assembly, antimicrobial resistance genes detection, and MLST determination were performed as before.
Web-based approaches. The fastq files containing the reads were uploaded into the BaseSpace website. First, the 
raw forward and reverse fastq reads were subjected to FASTQ Toolkit for adapter/quality trimming and length 
filtering with standard settings and length filtering adjusted to a minimum of 100 and a maximum of 500. The 
trimmed reads were then used as input for all the following processes. The available microorganism identification 
apps Kraken v1.0.0, MetaPhlAn v1.0.0 and GENIUS v.1.1.0 were used with the standard settings/parameters. 
SEAR was used to detect antimicrobial resistance genes, maintaining the standard settings except for the cluster-
ing stringency which was set to 0.98 and the annotation stringency was set to 40. The SPAdes Genome Assembler 
v3.9.0 app was run with the standard parameters for multi cell data type. For metagenomic datatype settings, the 
running mode was set to only assembly and careful mode was disabled.
The reads were uploaded into CosmosID (https://app.cosmosid.com/login) and Taxonomer24 (https://www.
taxonomer.com/) directly without any quality trimming. We used the Full Analysis mode in Taxonomer.
wgMLST analyses. Typing was done by MLST and wgMLST analyses obtained using Ridom SeqSphere + v4.0.1. 
The genomic data (assembled contigs) obtained from SMg was compared to the data obtained through WGS. 
Since no cg/wgMLST scheme was available for Escherichia coli, Enterococcus faecalis, Ochrobactrum interme-
dium and Staphylococcus haemolyticus, cgMLST and accessory genome schemes were constructed, using Ridom 
SeqSphere+ cgMLST Target Definer with the following parameters: a minimum length filter that removes all 
genes smaller than 50 bp; a start codon filter that discards all genes that contain no start codon at the beginning of 
the gene; a stop codon filter that discards all genes that contain no stop codon or more than one stop codon or that 
do not have the stop codon at the end of the gene; a homologous gene filter that discards all genes with fragments 
that occur in multiple copies within a genome (with identity of 90% and >100 bp overlap); and a gene overlap 
filter that discards the shorter gene from the cgMLST scheme if the two genes affected overlap >4 bp. The remain-
ing genes were then used in a pairwise comparison using BLAST version 2.2.12 (parameters used were word size 
11, mismatch penalty −1, match reward 1, gap open costs 5, and gap extension costs 2). All genes of the reference 
genome that were common in all query genomes with a sequence identity of ≥90% and 100% overlap and, with 
the default parameter stop codon percentage filter turned on, formed the final cgMLST scheme. The combination 
of all alleles in each strain formed an allelic profile that was used to generate minimum spanning trees using the 
parameter “pairwise ignore missing values” during distance calculation25.
Statistical analysis. The sensitivity and positive predictive value of each taxonomic classification method 
were determined. Classical culture and MALDI-TOF identifications were considered as the gold standard. The 
true positives were considered when the same bacterial species were identified by culture/MALDI-TOF and the 
taxonomic classification method. The false positives were detected when bacterial species different from those 
identified by culture/MALDI-TOF, were identified by the taxonomic classification method. The false negatives 
were determined when the bacterial species identified by culture/MALDI-TOF were not identified by the taxo-
nomic classification method.
Accession codes. The paired-trimmed-un-mapped reads (hg19) generated for each sample have been sub-
mitted to SRA under project number SRP126380. The cgMLST schemes are deposited in figshare under the 
DOI:10.6084/m9.figshare.5679376.
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